Cargando…
Safety and benefits of antenatal oral iron supplementation in low‐income countries: a review
The World Health Organization recommends universal iron supplementation of 30–60 mg/day in pregnancy but coverage is low in most countries. Its efficacy is uncertain, however, and there has been a vigorous debate in the last decade about its safety, particularly in areas with a high burden of malari...
Autores principales: | Mwangi, Martin N., Prentice, Andrew M., Verhoef, Hans |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485170/ https://www.ncbi.nlm.nih.gov/pubmed/28272734 http://dx.doi.org/10.1111/bjh.14584 |
Ejemplares similares
-
Safety and benefits of interventions to increase folate status in malaria‐endemic areas
por: Verhoef, Hans, et al.
Publicado: (2017) -
Hepcidin is the major predictor of erythrocyte iron incorporation in anemic African children
por: Prentice, Andrew M., et al.
Publicado: (2012) -
Efficacy and safety of deferasirox doses of >30 mg/kg per d in patients with transfusion-dependent anaemia and iron overload
por: Taher, Ali, et al.
Publicado: (2009) -
Long-term safety and efficacy of deferasirox (Exjade®) for up to 5 years in transfusional iron-overloaded patients with sickle cell disease
por: Vichinsky, Elliott, et al.
Publicado: (2011) -
Risk factors in underweight older children with sickle cell anemia: a comparison of low- to high-income countries
por: Klein, Lauren Jane, et al.
Publicado: (2023)